BPC-157 vs LL-37

BPC-157 wins for targeted soft-tissue healing, broad tolerability, and long track record of safety in the community. It excels at tendon, ligament, and gut repair where structural regeneration is the goal.

LL-37 wins for tackling difficult infections, breaking through biofilm-protected pathogens, and resolving chronic or post-surgical wounds complicated by microbial factors. It's the tool for resistant bacterial, viral, or fungal issues as much as wound closure.

BPC-157 is lower-maintenance and has a smoother side effect profile, making it the default for general recovery. LL-37 is more potent where active infection or biofilm disruption is involved but requires more caution for users prone to autoimmune flares or inflammatory skin disorders.

Pick BPC-157 if:

• You need accelerated recovery for tendon, ligament, or muscle injuries that aren't fully torn
• Post-surgical tissue healing or deep bruising where clean, rapid recovery matters
• Gut lining support (NSAID ulcers, "superdrol gut", chronic gastritis, or IBS-type symptoms)
• On-cycle maintenance for connective tissue on harsher PED runs
• Stacking a proven, well-tolerated healing peptide with TB-500 or GHK-Cu

Pick LL-37 if:

• Chronic or resistant bacterial, fungal, or viral infections (e.g., sinusitis, MRSA, mold aftermath)
• Disrupting biofilm-protected pathogens that antibiotics can't reach
• Wound care after surgery, hair transplant, or skin procedures, especially where infection risk is high
• Topical protocols for cystic acne or stubborn skin lesions that defy standard treatments
• Running a precision stack with thymosin alpha-1 or BPC-157 for multidimensional recovery, but you're already monitoring CRP/inflammatory markers